JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200

Watchlist Manager
JiangSu WuZhong Pharmaceutical Development Co Ltd Logo
JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
Watchlist
Price: 9.48 CNY 1.5% Market Closed
Market Cap: 6.7B CNY
Have any thoughts about
JiangSu WuZhong Pharmaceutical Development Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one JiangSu WuZhong Pharmaceutical Development Co Ltd stock under the Base Case scenario is 15.69 CNY. Compared to the current market price of 9.48 CNY, JiangSu WuZhong Pharmaceutical Development Co Ltd is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15.69 CNY
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
JiangSu WuZhong Pharmaceutical Development Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
JiangSu WuZhong Pharmaceutical Development Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for JiangSu WuZhong Pharmaceutical Development Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about JiangSu WuZhong Pharmaceutical Development Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

9.48 CNY
+1.5%
+1.5%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

JiangSu WuZhong Pharmaceutical Development Co Ltd
CN
Pharmaceuticals
Market Cap
6.8B CNY
IPO
Apr 1, 1999
Employees
1 067
China
Market Cap
6.8B CNY
Industry
Pharmaceuticals
IPO
Apr 1, 1999
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about JiangSu WuZhong Pharmaceutical Development Co Ltd

Provide an overview of the primary business activities
of JiangSu WuZhong Pharmaceutical Development Co Ltd.

What unique competitive advantages
does JiangSu WuZhong Pharmaceutical Development Co Ltd hold over its rivals?

What risks and challenges
does JiangSu WuZhong Pharmaceutical Development Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide P/S
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide P/E
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide P/OCF
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide P/FCFE
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide P/B
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide EV/S
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide EV/GP
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide EV/EBITDA
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide EV/EBIT
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide EV/OCF
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide EV/FCFF
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide EV/IC
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Show me price targets
for JiangSu WuZhong Pharmaceutical Development Co Ltd made by professional analysts.

What are the Revenue projections
for JiangSu WuZhong Pharmaceutical Development Co Ltd?

How accurate were the past Revenue estimates
for JiangSu WuZhong Pharmaceutical Development Co Ltd?

What are the Net Income projections
for JiangSu WuZhong Pharmaceutical Development Co Ltd?

How accurate were the past Net Income estimates
for JiangSu WuZhong Pharmaceutical Development Co Ltd?

What are the EPS projections
for JiangSu WuZhong Pharmaceutical Development Co Ltd?

How accurate were the past EPS estimates
for JiangSu WuZhong Pharmaceutical Development Co Ltd?

What are the EBIT projections
for JiangSu WuZhong Pharmaceutical Development Co Ltd?

How accurate were the past EBIT estimates
for JiangSu WuZhong Pharmaceutical Development Co Ltd?

Compare the revenue forecasts
for JiangSu WuZhong Pharmaceutical Development Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of JiangSu WuZhong Pharmaceutical Development Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of JiangSu WuZhong Pharmaceutical Development Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of JiangSu WuZhong Pharmaceutical Development Co Ltd compared to its peers.

Compare the P/E ratios
of JiangSu WuZhong Pharmaceutical Development Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing JiangSu WuZhong Pharmaceutical Development Co Ltd with its peers.

Analyze the financial leverage
of JiangSu WuZhong Pharmaceutical Development Co Ltd compared to its main competitors.

Show all profitability ratios
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide ROE
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide ROA
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide ROIC
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide ROCE
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide Gross Margin
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide Operating Margin
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide Net Margin
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide FCF Margin
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Show all solvency ratios
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide D/E Ratio
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide D/A Ratio
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide Interest Coverage Ratio
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide Altman Z-Score Ratio
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide Quick Ratio
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide Current Ratio
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Provide Cash Ratio
for JiangSu WuZhong Pharmaceutical Development Co Ltd.

What is the historical Revenue growth
over the last 5 years for JiangSu WuZhong Pharmaceutical Development Co Ltd?

What is the historical Net Income growth
over the last 5 years for JiangSu WuZhong Pharmaceutical Development Co Ltd?

What is the current Free Cash Flow
of JiangSu WuZhong Pharmaceutical Development Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for JiangSu WuZhong Pharmaceutical Development Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
JiangSu WuZhong Pharmaceutical Development Co Ltd

Current Assets 2.9B
Cash & Short-Term Investments 1.7B
Receivables 1B
Other Current Assets 227m
Non-Current Assets 1.2B
Long-Term Investments 506.9m
PP&E 260m
Intangibles 387m
Other Non-Current Assets 32.3m
Current Liabilities 2B
Accounts Payable 203.7m
Accrued Liabilities 25.8m
Short-Term Debt 1.6B
Other Current Liabilities 177.3m
Non-Current Liabilities 336m
Long-Term Debt 213.3m
Other Non-Current Liabilities 122.7m
Efficiency

Earnings Waterfall
JiangSu WuZhong Pharmaceutical Development Co Ltd

Revenue
2.4B CNY
Cost of Revenue
-1.7B CNY
Gross Profit
669.1m CNY
Operating Expenses
-632.9m CNY
Operating Income
36.2m CNY
Other Expenses
-74m CNY
Net Income
-37.8m CNY

Free Cash Flow Analysis
JiangSu WuZhong Pharmaceutical Development Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

JiangSu WuZhong Pharmaceutical Development Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Positive Gross Profit
Exceptional Revenue Growth Forecast
45/100
Profitability
Score

JiangSu WuZhong Pharmaceutical Development Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

JiangSu WuZhong Pharmaceutical Development Co Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Positive Net Debt
Average Altman Z-Score
54/100
Solvency
Score

JiangSu WuZhong Pharmaceutical Development Co Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
JiangSu WuZhong Pharmaceutical Development Co Ltd

Wall Street analysts forecast JiangSu WuZhong Pharmaceutical Development Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JiangSu WuZhong Pharmaceutical Development Co Ltd is 12.95 CNY with a low forecast of 12.83 CNY and a high forecast of 13.34 CNY.

Lowest
Price Target
12.83 CNY
35% Upside
Average
Price Target
12.95 CNY
37% Upside
Highest
Price Target
13.34 CNY
41% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for JiangSu WuZhong Pharmaceutical Development Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for JiangSu WuZhong Pharmaceutical Development Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one JiangSu WuZhong Pharmaceutical Development Co Ltd stock?

The intrinsic value of one JiangSu WuZhong Pharmaceutical Development Co Ltd stock under the Base Case scenario is 15.69 CNY.

Is JiangSu WuZhong Pharmaceutical Development Co Ltd stock undervalued or overvalued?

Compared to the current market price of 9.48 CNY, JiangSu WuZhong Pharmaceutical Development Co Ltd is Undervalued by 40%.

Back to Top